US Stock MarketDetailed Quotes
VIRI Virios Therapeutics
- 0.211
- +0.001+0.43%
Close Aug 23 16:00 ET
- 0.206
- -0.005-2.38%
Post 20:01 ET
5.84MMarket Cap-915P/E (TTM)
0.215High0.183Low6.95MVolume0.203Open0.210Pre Close1.77MTurnover27.58%Turnover RatioLossP/E (Static)27.76MShares1.25052wk High1.86P/B5.30MFloat Cap0.15652wk Low--Dividend TTM25.19MShs Float16.710Historical High--Div YieldTTM15.26%Amplitude0.156Historical Low0.254Avg Price1Lot Size
Virios Therapeutics Key Stats
Quarterly+Annual
YOY
| (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -9.34%-811.75K | 44.81%-937.41K | 57.53%-4.87M | 45.00%-1.47M | 61.32%-960.45K | 79.70%-742.41K | 36.05%-1.7M | 26.91%-11.47M | 48.41%-2.67M | 6.25%-2.48M |
| Net income from continuing operations | 27.14%-1.05M | 14.87%-1.29M | 56.76%-5.3M | 46.04%-1.1M | 52.05%-1.24M | 60.71%-1.44M | 61.70%-1.52M | 23.26%-12.25M | 54.68%-2.04M | 37.33%-2.58M |
| Change In working capital | -83.40%89.14K | 162.62%214.95K | -198.51%-194.45K | 33.76%-514.3K | 275.94%126.32K | 523.27%536.83K | -129.28%-343.28K | 478.18%197.38K | 2.80%-776.38K | -105.40%-71.79K |
| -Change in prepaid assets | -59.48%229.37K | -97.73%3.42K | 14.09%490.27K | -43.29%-385.71K | -42.21%159.2K | 484.14%566.08K | -73.60%150.69K | 571.53%429.74K | 68.24%-269.18K | -72.69%275.48K |
| -Change in payables and accrued expense | -379.30%-140.23K | 142.82%211.54K | -194.68%-684.71K | 74.65%-128.6K | 90.53%-32.89K | -242.48%-29.26K | -182.11%-493.97K | -696.61%-232.36K | -1,138.58%-507.2K | -208.34%-347.27K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -9.34%-811.75K | 44.81%-937.41K | 57.53%-4.87M | 45.00%-1.47M | 61.32%-960.45K | 79.70%-742.41K | 36.05%-1.7M | 26.91%-11.47M | 48.41%-2.67M | 6.25%-2.48M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | ||||||||||
| Cash from discontinued investing activities | ||||||||||
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -74.25%1.16M | 0 | 1.16M | 4,700.84%4.49M | -86K | |||||
| Net common stock issuance | ---- | ---- | -74.25%1.16M | --0 | --1.16M | ---- | ---- | 1,621.38%4.49M | 70.87%-86K | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | ---- | ---- | -74.25%1.16M | --0 | -74.73%1.16M | ---- | ---- | 4,700.84%4.49M | ---86K | --4.58M |
| Net cash flow | ||||||||||
| Beginning cash position | -55.38%2.38M | -52.82%3.32M | -49.81%7.03M | -51.10%4.79M | -40.35%4.59M | -53.03%5.33M | -49.81%7.03M | -52.99%14.01M | -48.98%9.79M | -64.76%7.7M |
| Current changes in cash | 186.29%640.65K | 44.81%-937.41K | 46.77%-3.71M | 46.72%-1.47M | -90.64%195.99K | 79.70%-742.41K | 36.05%-1.7M | 55.80%-6.98M | 46.75%-2.76M | 179.03%2.09M |
| End cash Position | -34.20%3.02M | -55.38%2.38M | -52.82%3.32M | -52.82%3.32M | -51.10%4.79M | -40.35%4.59M | -53.03%5.33M | -49.81%7.03M | -49.81%7.03M | -48.98%9.79M |
| Free cash flow | -9.34%-811.75K | 44.81%-937.41K | 57.53%-4.87M | 45.00%-1.47M | 61.32%-960.45K | 79.70%-742.41K | 36.05%-1.7M | 26.91%-11.47M | 48.41%-2.67M | 6.25%-2.48M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion | -- | -- | -- | -- | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg